Home › Post-COVID Conditions (Long COVID) › NCT05639465
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
Pragmatic RCT of a Multi-level Mechanistically Informed Community Intervention to Prevent the Onset of Behavioral Health Symptoms Among Socioeconomically Disadvantaged Pandemic Affected Children
Who can join
Ages 8 to 14 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * child experienced the COVID-19 pandemic and an additional large-scale disaster * child score is 5 or above on the Strengths and Difficulties Questionnaire * child is in 3- 8th grade at enrollment * the parent or guardian must complete informed consent and child assent * child must speak English or Spanish. Exclusion Criteria: * child is currently receiving treatment for a diagnosed mental health condition * children who are not able to interact with other students in a group work format, regardless of IEP status
About the study
Racial and ethnic minority children who live in socioeconomically disadvantaged communities are disproportionately impacted by pandemic and climate-induced disasters. Although effective interventions have been designed to treat mental health related symptoms in post-disaster settings, accessible, empirically supported prevention interventions are needed to prevent the onset of mental and behavioral health issues among these children. Building on our preliminary findings, the proposed study examines the efficacy and implementation of a COVID-19 adapted disaster focused prevention intervention, Journey of Hope-C19, in preventing behavioral health and interpersonal problems among racial and ethnic minority children who live in low-resource high poverty communities.
What is being tested
- JoH-C19 (behavioral)
- Switch off Get Active (behavioral)
Sponsor: University of Illinois at Urbana-Champaign · Participants: 800 · Started: Nov 15, 2022
Contact the study team
- Tara Leytham Powell, PhD · Phone: 2173000917
Official record on ClinicalTrials.gov — NCT05639465
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.